Clinical Trial

Long COVID Diagnostic Reactivity Assesment Test

Study acronym: EAV-LONGCOVID
Enrolling by Invitation
View on ClinicalTrials.gov →
Summary
This study is a diagnostic clinical investigation designed to evaluate bioelectrical response patterns assessed by electro-acupuncture-based medicament testing. The method is used to identify individual bioelectrical reactivity associated with the presence and persistence of pathological factors and to assess patient-specific responses to tested medicinal substances. The study involves a single-session, non-invasive diagnostic procedure without administration of pharmacological treatment. The primary objective is the methodological evaluation of the diagnostic approach and the characterization of the detected bioelectrical response patterns in the studied population.
Trial Details
NCT Number NCT07343856
Lead Sponsor Oncology Center,Ministry Of Heath,Uzbekistan
Conditions Long COVID, Post-Acute Sequelae of SARS-CoV-2 Infection
Enrollment 50 participants
Start Date 2025-12-05
Primary Completion 2026-12-30 (estimated)
Study Completion 2027-01-01 (estimated)
Updated on ClinicalTrials.gov 2026-01-15